Difference between revisions of "BRST5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
(Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo...")
 
 
(47 intermediate revisions by 2 users not shown)
Line 6: Line 6:
  
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
−
 
+
__TOC__
−
==WHO Classification of Tumours of the Breast (5th Edition) Content==
+
<br />
−
{| class="wikitable"
+
{| class="wikitable" style="margin:auto"
 +
|+<big>WHO Classification of Tumours of the Breast (5th Edition) Content</big>
 
|-
 
|-
 
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
 
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
Line 17: Line 18:
 
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
−
|- |Usual ductal hyperplasia||Disease||
+
|-
−
|Usual Ductal Hyperplasia
+
|
−
|Disease
+
====CHAPTER 2 (EPITHELIAL TUMOURS OF THE BREAST)====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|Columnar Cell Lesions, Including Flat Epithelial Atypia||Disease||
+
|Usual ductal hyperplasia
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 35: Line 51:
 
|
 
|
 
|-
 
|-
−
|Atypical Ductal Hyperplasia||Disease||
+
|Columnar cell lesions, including flat epithelial atypia||Disease||
 
|
 
|
 
|
 
|
Line 44: Line 60:
 
|
 
|
 
|-
 
|-
−
|Sclerosing Adenosis||Disease||
+
|Atypical ductal hyperplasia||Disease||
 
|
 
|
 
|
 
|
Line 53: Line 69:
 
|
 
|
 
|-
 
|-
−
|Apocrine Adenosis and Adenoma||Disease||
+
|Sclerosing adenosis||Disease||
 
|
 
|
 
|
 
|
Line 62: Line 78:
 
|
 
|
 
|-
 
|-
−
|Microglandular Adenosis||Disease||
+
|Apocrine adenosis and adenoma||Disease||
 
|
 
|
 
|
 
|
Line 71: Line 87:
 
|
 
|
 
|-
 
|-
−
|Radial Scar/Complex Sclerosing Lesion||Disease||
+
|Microglandular adenosis||Disease||
 
|
 
|
 
|
 
|
Line 80: Line 96:
 
|
 
|
 
|-
 
|-
−
|Tubular Adenoma||Disease||
+
|Radial scar/complex sclerosing lesion||Disease||
 
|
 
|
 
|
 
|
Line 89: Line 105:
 
|
 
|
 
|-
 
|-
−
|Lactating Adenoma||Disease||
+
|Tubular adenoma||Disease||
 
|
 
|
 
|
 
|
Line 98: Line 114:
 
|
 
|
 
|-
 
|-
−
|Ductal Adenoma||Disease||
+
|Lactating adenoma||Disease||
 
|
 
|
 
|
 
|
Line 107: Line 123:
 
|
 
|
 
|-
 
|-
−
|Pleomorphic Adenoma||Disease||
+
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|Ductal adenoma||Disease||
 
|
 
|
 
|
 
|
Line 116: Line 143:
 
|
 
|
 
|-
 
|-
−
|Adenomyoepithelioma||Disease||
+
|Pleomorphic adenoma||Disease||
 
|
 
|
 
|
 
|
Line 125: Line 152:
 
|
 
|
 
|-
 
|-
−
|Malignant Adenomyoepithelioma||Disease||
+
|Adenomyoepithelioma||Disease||
 
|
 
|
 
|
 
|
Line 134: Line 161:
 
|
 
|
 
|-
 
|-
−
|Intraductal Papilloma||Disease||
+
|Malignant adenomyoepithelioma||Disease||
 
|
 
|
 
|
 
|
Line 143: Line 170:
 
|
 
|
 
|-
 
|-
−
|Papillary Ductal Carcinoma In Situ||Disease||
+
|Intraductal papilloma||Disease||
 
|
 
|
 
|
 
|
Line 152: Line 179:
 
|
 
|
 
|-
 
|-
−
|Encapsulated Papillary Carcinoma||Disease||
+
|Papillary ductal carcinoma in situ||Disease||
 
|
 
|
 
|
 
|
Line 161: Line 188:
 
|
 
|
 
|-
 
|-
−
|Solid Papillary Carcinoma (In Situ and Invasive)||Disease||
+
|Encapsulated papillary carcinoma||Disease||
 
|
 
|
 
|
 
|
Line 170: Line 197:
 
|
 
|
 
|-
 
|-
−
|Invasive Papillary Carcinoma||Disease||
+
|Solid papillary carcinoma (in situ and invasive)||Disease||
 
|
 
|
 
|
 
|
Line 179: Line 206:
 
|
 
|
 
|-
 
|-
−
|Atypical Lobular Hyperplasia||Disease||
+
|Invasive papillary carcinoma||Disease||
 
|
 
|
 
|
 
|
Line 188: Line 215:
 
|
 
|
 
|-
 
|-
−
|Lobular Carcinoma In Situ||Disease||
+
|Atypical lobular hyperplasia||Disease||
 
|
 
|
 
|
 
|
Line 197: Line 224:
 
|
 
|
 
|-
 
|-
−
|Ductal Carcinoma In Situ||Disease||
+
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|Lobular carcinoma in situ||Disease||
 
|
 
|
 
|
 
|
Line 206: Line 244:
 
|
 
|
 
|-
 
|-
−
|Invasive Breast Carcinoma of No Special Type||Disease||
+
|Ductal carcinoma in situ||Disease||
 
|
 
|
 
|
 
|
Line 215: Line 253:
 
|
 
|
 
|-
 
|-
−
|Microinvasive Carcinoma||Disease||
+
|Invasive breast carcinoma of no special type||Disease||
 
|
 
|
 
|
 
|
Line 224: Line 262:
 
|
 
|
 
|-
 
|-
−
|Invasive lobular Carcinoma||Disease||
+
|Microinvasive carcinoma||Disease||
 
|
 
|
 
|
 
|
Line 233: Line 271:
 
|
 
|
 
|-
 
|-
−
|Tubular Carcinoma||Disease||
+
|Invasive lobular carcinoma||Disease||
 
|
 
|
 
|
 
|
Line 242: Line 280:
 
|
 
|
 
|-
 
|-
−
|Cribriform Carcinoma||Disease||
+
|Tubular carcinoma||Disease||
 
|
 
|
 
|
 
|
Line 251: Line 289:
 
|
 
|
 
|-
 
|-
−
|Mucinous Carcinoma||Disease||
+
|Cribriform carcinoma||Disease||
 
|
 
|
 
|
 
|
Line 260: Line 298:
 
|
 
|
 
|-
 
|-
−
|Mucinous Cystadenocarcinoma||Disease||
+
|Mucinous carcinoma||Disease||
 
|
 
|
 
|
 
|
Line 269: Line 307:
 
|
 
|
 
|-
 
|-
−
|Invasive Micropapillary Carcinoma||Disease||
+
|Mucinous cystadenocarcinoma||Disease||
 
|
 
|
 
|
 
|
Line 278: Line 316:
 
|
 
|
 
|-
 
|-
−
|Carcinoma with Apocrine Differentiation||Disease||
+
|Invasive micropapillary carcinoma||Disease||
 
|
 
|
 
|
 
|
Line 287: Line 325:
 
|
 
|
 
|-
 
|-
−
|Metaplastic Carcinoma||Disease||
+
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|Carcinoma with apocrine differentiation||Disease||
 
|
 
|
 
|
 
|
Line 296: Line 345:
 
|
 
|
 
|-
 
|-
−
|Acinic Cell Carcinoma||Disease||
+
|Metaplastic carcinoma||Disease||
 
|
 
|
 
|
 
|
Line 305: Line 354:
 
|
 
|
 
|-
 
|-
−
|Adenoid Cystic Carcinoma||Disease||Katherine Geiersbach / Jun Liao
+
|[[BRST5:Acinic cell carcinoma|Acinic cell carcinoma]]||Disease||Patricija Zot
 +
|2/28/2024
 +
|
 +
|PENDING
 +
|
 +
|Katherine Geiersbach
 +
|
 +
|
 +
|-
 +
|[[BRST5:Adenoid cystic carcinoma|Adenoid cystic carcinoma]]||Disease||Katherine Geiersbach / Jun Liao
 
|10/12/02022
 
|10/12/02022
 
|11/11/2023
 
|11/11/2023
Line 314: Line 372:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Secretory Carcinoma||Disease||Hui Chen / Morteza Seifi
+
|[[BRST5:Secretory carcinoma|Secretory carcinoma]]||Disease||Hui Chen / Morteza Seifi
 
|10/12/2022
 
|10/12/2022
 
|11/11/2023
 
|11/11/2023
−
|PENDING
+
|COMPLETE
 
|
 
|
 
|Katherine Geiersbach
 
|Katherine Geiersbach
Line 323: Line 381:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Mucoepidermoid Carcinoma||Disease||
+
|Mucoepidermoid carcinoma||Disease||
 
|
 
|
 
|
 
|
Line 332: Line 390:
 
|
 
|
 
|-
 
|-
−
|Polymorphous Adenocarcinoma||Disease||
+
|Polymorphous adenocarcinoma||Disease||
 
|
 
|
 
|
 
|
Line 341: Line 399:
 
|
 
|
 
|-
 
|-
−
|Tall Cell Carcinoma with Reversed Polarity||Disease||H. Evin Gulbahce
+
|[[BRST5:Tall cell carcinoma with reversed polarity|Tall cell carcinoma with reversed polarity]]||Disease||H. Evin Gulbahce
 
|8/11/2023
 
|8/11/2023
 
|10/11/2023
 
|10/11/2023
Line 350: Line 408:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Neuroendocrine Tumour||Disease||
+
|Neuroendocrine tumour||Disease||
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|Neuroendocrine carcinoma||Disease||
 
|
 
|
 
|
 
|
Line 359: Line 426:
 
|
 
|
 
|-
 
|-
−
|Neuroendocrine Carcinoma||Disease||
+
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|
 +
====CHAPTER 3 (FIBROEPITHELIAL TUMOURS AND HAMARTOMAS OF THE BREAST)====
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
 
|Hamartoma||Disease||
 
|Hamartoma||Disease||
Line 377: Line 467:
 
|
 
|
 
|-
 
|-
−
|Fibroadenoma||Disease||H. Evin Gulbahce / Patricija Zot
+
|[[BRST5:Fibroadenoma|Fibroadenoma]]||Disease||H. Evin Gulbahce / Patricija Zot
 
|8/11/2023
 
|8/11/2023
 
|11/11/2023
 
|11/11/2023
Line 386: Line 476:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Phyllodes Tumour||Disease||H. Evin Gulbahce / Patricija Zot / Emilie Lalonde / Katherine Geiersbach
+
|[[BRST5:Phyllodes tumour|Phyllodes tumour]]||Disease||Emilie Lalonde / H. Evin Gulbahce /Katherine Geiersbach
 
|8/11/2023
 
|8/11/2023
 
|11/11/2023
 
|11/11/2023
−
|PENDING
+
|COMPLETE
 
|
 
|
 
|
 
|
Line 395: Line 485:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Syringomatous Tumour||Disease||
+
|
 +
====CHAPTER 4 (TUMOURS OF THE NIPPLE)====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|Syringomatous tumour||Disease||
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|Nipple adenoma||Disease||
 
|
 
|
 
|
 
|
Line 404: Line 524:
 
|
 
|
 
|-
 
|-
−
|Nipple Adenoma||Disease||
+
|Paget disease of the breast||Disease||
 
|
 
|
 
|
 
|
Line 413: Line 533:
 
|
 
|
 
|-
 
|-
−
|Paget disease of the Breast||Disease||
 
 
|
 
|
 +
====CHAPTER 5 (MESENCHYMAL TUMOURS OF THE BREAST)====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
 
|Haemangioma||Disease||
 
|Haemangioma||Disease||
Line 430: Line 562:
 
|
 
|
 
|
 
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|Angiomatosis||Disease||
 
|Angiomatosis||Disease||
Line 440: Line 583:
 
|
 
|
 
|-
 
|-
−
|Atypical Vascular Lesions||Disease||
+
|Atypical vascular lesions||Disease||
 
|
 
|
 
|
 
|
Line 449: Line 592:
 
|
 
|
 
|-
 
|-
−
|Postradiation Angiosarcoma of the Breast||Disease||
+
|Postradiation angiosarcoma of the breast||Disease||
 
|
 
|
 
|
 
|
Line 458: Line 601:
 
|
 
|
 
|-
 
|-
−
|Primary Angiosarcoma of the Breast||Disease||
+
|Primary angiosarcoma of the breast||Disease||
 
|
 
|
 
|
 
|
Line 467: Line 610:
 
|
 
|
 
|-
 
|-
−
|Nodular Fasciitis||Disease||
+
|Nodular fasciitis||Disease||
 
|
 
|
 
|
 
|
Line 485: Line 628:
 
|
 
|
 
|-
 
|-
−
|Desmoid Fibromatosis||Disease||
+
|Desmoid fibromatosis||Disease||
 
|
 
|
 
|
 
|
Line 494: Line 637:
 
|
 
|
 
|-
 
|-
−
|Inflammatory Myofibroblastic Tumour||Disease||Yajuan Liu
+
|[[BRST5:Inflammatory myofibroblastic tumour|Inflammatory myofibroblastic tumour]]||Disease||Yajuan Liu
 
|8/11/2023
 
|8/11/2023
 
|11/11/2023
 
|11/11/2023
Line 521: Line 664:
 
|
 
|
 
|-
 
|-
−
|Granular Cell Tumour||Disease||
+
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|Granular cell tumour||Disease||
 
|
 
|
 
|
 
|
Line 575: Line 729:
 
|
 
|
 
|-
 
|-
−
|Pseudoangiomatous Stromal Hyperplasia||Disease||
+
|Pseudoangiomatous stromal hyperplasia||Disease||
 
|
 
|
 
|
 
|
Line 584: Line 738:
 
|
 
|
 
|-
 
|-
−
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||
 
 
|
 
|
 +
====CHAPTER 6 (HAEMATOLYMPHOID TUMOURS OF THE BREAST)====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Follicular Lymphoma||Disease||
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|Diffuse Large B-cell Lymphoma||Disease||
+
|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)||Disease||
 
|
 
|
 
|
 
|
Line 611: Line 768:
 
|
 
|
 
|-
 
|-
−
|Burkitt Lymphoma||Disease||
+
|Follicular lymphoma||Disease||
 
|
 
|
 
|
 
|
Line 620: Line 777:
 
|
 
|
 
|-
 
|-
−
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||
+
!'''Disease'''
−
|
+
!'''Page Type'''
−
|
+
!'''<span style="color:#0070C0">Author'''
−
|
+
!'''Date Assigned to Author'''
−
|
+
!'''Target Completion Date'''
−
|
+
!'''Author Content (Pending or Complete)'''
−
|
+
!'''Date Completed by Author'''
−
|
+
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
−
|Gynaecomastia||Disease||
+
|Diffuse large B-cell lymphoma||Disease||
 
|
 
|
 
|
 
|
Line 638: Line 797:
 
|
 
|
 
|-
 
|-
−
|Carcinoma In Situ||Disease||
+
|Burkitt lymphoma||Disease||
 
|
 
|
 
|
 
|
Line 647: Line 806:
 
|
 
|
 
|-
 
|-
−
|Invasive Carcinoma||Disease||
+
|Breast implant-associated anaplastic large cell lymphoma||Disease||
 
|
 
|
 
|
 
|
Line 656: Line 815:
 
|
 
|
 
|-
 
|-
−
|Metastases to the Breast||Disease||
 
 
|
 
|
 +
====CHAPTER 7 (TUMOURS OF THE MALE BREAST)====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||Constance Albarracin / Katherine Geiersbach
 
−
|12/6/2023
 
−
|3/6/2024
 
−
|
 
−
|
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|Cowden Syndrome||Disease||
+
|Gynaecomastia||Disease||
 
|
 
|
 
|
 
|
Line 683: Line 845:
 
|
 
|
 
|-
 
|-
−
|Ataxia-Telangiectasia||Disease||Evin Gulbahce / Katherine Geiersbach
+
|Carcinoma in situ||Disease||
−
|12/11/2023
 
−
|3/11/2024
 
−
|
 
−
|
 
−
|Katherine Geiersbach
 
−
|
 
−
|
 
−
|-
 
−
|Li-Fraumeni Syndrome, TP53-Associated||Disease||
 
 
|
 
|
 
|
 
|
Line 701: Line 854:
 
|
 
|
 
|-
 
|-
−
|Li-Fraumeni Syndrome, CHEK2-Associated||Disease||
+
|Invasive carcinoma||Disease||
 
|
 
|
 
|
 
|
Line 710: Line 863:
 
|
 
|
 
|-
 
|-
−
|CDH1-Associated Breast Cancer||Disease||
+
|Metastases to the breast||Disease||
 
|
 
|
 
|
 
|
Line 719: Line 872:
 
|
 
|
 
|-
 
|-
−
|PALB2-Associated Cancers||Disease||Constance Albarracin / Katherine Geiersbach
 
−
|12/8/2023
 
−
|3/8/2024
 
 
|
 
|
 +
====CHAPTER 8 (GENETIC TUMOUR SYNDROMES OF THE BREAST)====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Peutz-Jeghers Syndrome||Disease||
 
−
|
 
−
|
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[BRST5:BRCA1/2-associated hereditary breast and ovarian cancer syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|[[BRST5:Cowden syndrome|Cowden syndrome]]||Disease||[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[BRST5:Ataxia-telangiectasia|Ataxia-telangiectasia]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[BRST5:Li-Fraumeni syndrome, TP53-associated|Li-Fraumeni syndrome, TP53-associated]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[BRST5:Li-Fraumeni syndrome, CHEK2-associated|Li-Fraumeni syndrome, CHEK2-associated]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[BRST5:CDH1-associated breast cancer|CDH1-associated breast cancer]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[BRST5:PALB2-associated cancers|PALB2-associated cancers]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[BRST5:Peutz-Jeghers syndrome|Peutz-Jeghers syndrome]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 
|-
 
|-
−
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
+
|[[GTS5:Neurofibromatosis type 1 (NF1)|Neurofibromatosis type 1]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
+
|N/A
 
|-
 
|-
−
|Polygenic Component of Breast Cancer Susceptibility
+
|[[BRST5:Polygenic component of breast cancer susceptibility|Polygenic component of breast cancer susceptibility]]
 
|Disease
 
|Disease
 +
|Xiaolin Hu
 +
|6/4/2024
 
|
 
|
 
|
 
|
Line 753: Line 994:
 
|
 
|
 
|
 
|
−
|
+
|Template added (6/4/24)
−
|
 
−
|
 
 
|-
 
|-
 
|}<br />
 
|}<br />

Latest revision as of 13:52, 10 September 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.


WHO Classification of Tumours of the Breast (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (EPITHELIAL TUMOURS OF THE BREAST)
Usual ductal hyperplasia Disease
Columnar cell lesions, including flat epithelial atypia Disease
Atypical ductal hyperplasia Disease
Sclerosing adenosis Disease
Apocrine adenosis and adenoma Disease
Microglandular adenosis Disease
Radial scar/complex sclerosing lesion Disease
Tubular adenoma Disease
Lactating adenoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Ductal adenoma Disease
Pleomorphic adenoma Disease
Adenomyoepithelioma Disease
Malignant adenomyoepithelioma Disease
Intraductal papilloma Disease
Papillary ductal carcinoma in situ Disease
Encapsulated papillary carcinoma Disease
Solid papillary carcinoma (in situ and invasive) Disease
Invasive papillary carcinoma Disease
Atypical lobular hyperplasia Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Lobular carcinoma in situ Disease
Ductal carcinoma in situ Disease
Invasive breast carcinoma of no special type Disease
Microinvasive carcinoma Disease
Invasive lobular carcinoma Disease
Tubular carcinoma Disease
Cribriform carcinoma Disease
Mucinous carcinoma Disease
Mucinous cystadenocarcinoma Disease
Invasive micropapillary carcinoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Carcinoma with apocrine differentiation Disease
Metaplastic carcinoma Disease
Acinic cell carcinoma Disease Patricija Zot 2/28/2024 PENDING Katherine Geiersbach
Adenoid cystic carcinoma Disease Katherine Geiersbach / Jun Liao 10/12/02022 11/11/2023 COMPLETE Hui Chen / Katherine Geiersbach 12/6/2023 2021 template added
Secretory carcinoma Disease Hui Chen / Morteza Seifi 10/12/2022 11/11/2023 COMPLETE Katherine Geiersbach 2021 template added
Mucoepidermoid carcinoma Disease
Polymorphous adenocarcinoma Disease
Tall cell carcinoma with reversed polarity Disease H. Evin Gulbahce 8/11/2023 10/11/2023 COMPLETE Katherine Geiersbach 2021 template added
Neuroendocrine tumour Disease
Neuroendocrine carcinoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 3 (FIBROEPITHELIAL TUMOURS AND HAMARTOMAS OF THE BREAST)
Hamartoma Disease
Fibroadenoma Disease H. Evin Gulbahce / Patricija Zot 8/11/2023 11/11/2023 PENDING 2021 template added
Phyllodes tumour Disease Emilie Lalonde / H. Evin Gulbahce /Katherine Geiersbach 8/11/2023 11/11/2023 COMPLETE 2021 template added

CHAPTER 4 (TUMOURS OF THE NIPPLE)
Syringomatous tumour Disease
Nipple adenoma Disease
Paget disease of the breast Disease

CHAPTER 5 (MESENCHYMAL TUMOURS OF THE BREAST)
Haemangioma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Angiomatosis Disease
Atypical vascular lesions Disease
Postradiation angiosarcoma of the breast Disease
Primary angiosarcoma of the breast Disease
Nodular fasciitis Disease
Myofibroblastoma Disease
Desmoid fibromatosis Disease
Inflammatory myofibroblastic tumour Disease Yajuan Liu 8/11/2023 11/11/2023 COMPLETE Katherine Geiersbach 12/6/2023 2021 template added
Schwannoma Disease
Neurofibroma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Granular cell tumour Disease
Leiomyoma Disease
Leiomyosarcoma Disease
Lipoma Disease
Angiolipoma Disease
Liposarcoma Disease
Pseudoangiomatous stromal hyperplasia Disease

CHAPTER 6 (HAEMATOLYMPHOID TUMOURS OF THE BREAST)
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) Disease
Follicular lymphoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Diffuse large B-cell lymphoma Disease
Burkitt lymphoma Disease
Breast implant-associated anaplastic large cell lymphoma Disease

CHAPTER 7 (TUMOURS OF THE MALE BREAST)
Gynaecomastia Disease
Carcinoma in situ Disease
Invasive carcinoma Disease
Metastases to the breast Disease

CHAPTER 8 (GENETIC TUMOUR SYNDROMES OF THE BREAST)
BRCA1/2-associated hereditary breast and ovarian cancer syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Cowden syndrome Disease See DIG5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Ataxia-telangiectasia Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Li-Fraumeni syndrome, TP53-associated Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Li-Fraumeni syndrome, CHEK2-associated Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
CDH1-associated breast cancer Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
PALB2-associated cancers Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Peutz-Jeghers syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Polygenic component of breast cancer susceptibility Disease Xiaolin Hu 6/4/2024 Template added (6/4/24)


Retrieved from "https://ccga.io/index.php?title=BRST5:Volunteer_Assignments_and_Opportunities&oldid=15411"